XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Redeemable convertible preferred stock beginning balance at Dec. 31, 2024         $ 85,503
Redeemable convertible preferred stock beginning balance (in shares) at Dec. 31, 2024         3,963,910
Redeemable convertible preferred stock ending balance at Mar. 31, 2025         $ 85,503
Redeemable convertible preferred stock ending balance (in shares) at Mar. 31, 2025         3,963,910
Beginning balance at Dec. 31, 2024 $ 2 $ 1,103 $ (92,236)   $ (91,131)
Beginning balance (in shares) at Dec. 31, 2024 2,574,767        
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)          
Exercise of stock options   3     3
Exercise of stock options (in shares) 727        
Stock-based compensation   80     80
Unrealized gain (loss) on short-term investments       $ 2 2
Net (loss) income     (9,579)   (9,579)
Ending balance at Mar. 31, 2025 $ 2 1,186 (101,815) 2 (100,625)
Ending balance (in shares) at Mar. 31, 2025 2,575,494        
Redeemable convertible preferred stock beginning balance at Dec. 31, 2024         $ 85,503
Redeemable convertible preferred stock beginning balance (in shares) at Dec. 31, 2024         3,963,910
Beginning balance at Dec. 31, 2024 $ 2 1,103 (92,236)   $ (91,131)
Beginning balance (in shares) at Dec. 31, 2024 2,574,767        
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)          
Unrealized gain (loss) on short-term investments         (13)
Net (loss) income         (5,412)
Ending balance at Jun. 30, 2025 $ 9 130,579 (97,648) (13) 32,927
Ending balance (in shares) at Jun. 30, 2025 9,373,433        
Redeemable convertible preferred stock beginning balance at Mar. 31, 2025         $ 85,503
Redeemable convertible preferred stock beginning balance (in shares) at Mar. 31, 2025         3,963,910
Redeemable Convertible Preferred Stock          
Conversion of redeemable convertible preferred stock into common stock in connection with the Merger         $ (85,503)
Conversion of redeemable convertible preferred stock into common stock in connection with the Merger (in shares)         (3,963,910)
Beginning balance at Mar. 31, 2025 $ 2 1,186 (101,815) 2 $ (100,625)
Beginning balance (in shares) at Mar. 31, 2025 2,575,494        
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)          
Exercise of stock options   421     421
Exercise of stock options (in shares) 17,891        
Stock-based compensation   627     627
Conversion of redeemable convertible preferred stock into common stock in connection with the Merger $ 4 85,499     85,503
Conversion of redeemable convertible preferred stock into common stock in connection with the Merger (in shares) 3,963,910        
Issuance of common stock upon the conversion of Convertible Notes $ 1 23,099     23,100
Issuance of common stock upon the conversion of Convertible Notes (in shares) 1,265,757        
Issuance of common stock in connection with the Merger $ 2 23,871     23,873
Issuance of common stock in connection with the Merger (in shares) 1,550,381        
Transaction costs in connection with the Merger   (4,124)     (4,124)
Unrealized gain (loss) on short-term investments       (15) (15)
Net (loss) income     4,167   4,167
Ending balance at Jun. 30, 2025 $ 9 130,579 (97,648) (13) 32,927
Ending balance (in shares) at Jun. 30, 2025 9,373,433        
Beginning balance at Dec. 31, 2025 $ 9 131,379 (110,450) 8 $ 20,946
Beginning balance (in shares) at Dec. 31, 2025 9,381,344       9,381,344
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)          
Stock-based compensation   370     $ 370
Unrealized gain (loss) on short-term investments       (7) (7)
Net (loss) income     (6,804)   (6,804)
Ending balance at Mar. 31, 2026 $ 9 131,749 (117,254) 1 14,505
Ending balance (in shares) at Mar. 31, 2026 9,381,344        
Beginning balance at Dec. 31, 2025 $ 9 131,379 (110,450) 8 $ 20,946
Beginning balance (in shares) at Dec. 31, 2025 9,381,344       9,381,344
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)          
Exercise of stock options (in shares)         0
Unrealized gain (loss) on short-term investments         $ (8)
Net (loss) income         (13,261)
Ending balance at Jun. 30, 2026 $ 9 132,084 (123,711)   $ 8,382
Ending balance (in shares) at Jun. 30, 2026 9,381,344       9,381,344
Beginning balance at Mar. 31, 2026 $ 9 131,749 (117,254) 1 $ 14,505
Beginning balance (in shares) at Mar. 31, 2026 9,381,344        
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)          
Exercise of stock options (in shares)         0
Stock-based compensation   335     $ 335
Unrealized gain (loss) on short-term investments       $ (1) (1)
Net (loss) income     (6,457)   (6,457)
Ending balance at Jun. 30, 2026 $ 9 $ 132,084 $ (123,711)   $ 8,382
Ending balance (in shares) at Jun. 30, 2026 9,381,344       9,381,344